ArrowMark Colorado Holdings LLC - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 105 filers reported holding ALBIREO PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
ArrowMark Colorado Holdings LLC ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$16,999,809
+11.0%
786,664
-0.6%
0.20%
+8.0%
Q3 2022$15,319,000
+27.1%
791,249
+30.4%
0.19%
+36.2%
Q2 2022$12,054,000
-36.9%
606,963
-5.3%
0.14%
-17.4%
Q1 2022$19,118,000
+29.0%
640,893
+0.7%
0.17%
+40.3%
Q4 2021$14,820,000
-24.6%
636,346
+1.1%
0.12%
-22.7%
Q3 2021$19,643,000
-18.1%
629,577
-7.7%
0.15%
-14.9%
Q2 2021$23,993,000
-2.6%
682,001
-2.4%
0.18%
-1.6%
Q1 2021$24,631,000
-12.6%
698,747
-7.0%
0.18%
-15.6%
Q4 2020$28,189,000
+5.8%
751,495
-5.9%
0.22%
-14.2%
Q3 2020$26,648,000
+5.1%
798,564
-16.6%
0.25%
-3.1%
Q2 2020$25,351,000
+59.3%
956,990
-1.6%
0.26%
+25.4%
Q1 2020$15,918,000
-27.8%
972,372
+12.1%
0.21%
+6.6%
Q4 2019$22,040,000
+76.8%
867,050
+39.1%
0.20%
+58.1%
Q3 2019$12,468,000
-30.4%
623,380
+12.2%
0.12%
-27.9%
Q2 2019$17,917,000
-15.8%
555,728
-15.9%
0.17%
-14.0%
Q1 2019$21,273,000
+41.7%
660,442
+7.9%
0.20%
+26.6%
Q4 2018$15,012,000
-18.1%
611,992
+10.1%
0.16%
+3.3%
Q3 2018$18,328,000
+0.6%
556,067
+8.3%
0.15%
-8.4%
Q2 2018$18,220,000
+38.0%
513,249
+26.6%
0.17%
+26.5%
Q1 2018$13,202,000405,3520.13%
Other shareholders
ALBIREO PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Prosight Management, LP 514,082$11,973,0007.17%
Privium Fund Management B.V. 379,117$8,959,0001.78%
Birchview Capital, LP 113,000$2,632,0001.70%
Sio Capital Management, LLC 213,913$4,982,0001.50%
Perceptive Advisors 4,720,278$109,936,0000.85%
Chicago Capital, LLC 849,239$19,779,0000.74%
APOGEM CAPITAL LLC 38,601$899,0000.59%
Samsara BioCapital, LLC 100,000$2,329,0000.45%
Artal Group S.A. 600,000$13,974,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 458,011$10,667,0000.38%
View complete list of ALBIREO PHARMA INC shareholders